mAb therapy (Recalcine/Institut Pasteur)
N/A
Report date: 2025/03/20 20:00:06
Base Information
Drug NamemAb therapy (Recalcine/Institut Pasteur)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRecalcine Pharmaceutical Corp
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesRecalcine Pharmaceutical CorpInstitut Pasteur
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A